Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 1, 2009
Ecstasy Users at Higher Risk of Sleep Apnea
December 1, 2009The widely used club drug ecstasy appears to increase the risk of sleep apnea, say U.S. researchers.
"People who use ecstasy need to know that this drug damages the brain and can cause immediate and dangerous problems such as sleep apnea," study author Dr. Una McCann, of the Johns Hopkins School of Medicine in Baltimore, said in a news release.
McCann and colleagues conducted sleep tests on 71 people who'd used ecstasy (MDMA) and 62 people who'd never used the illegal drug. Ecstasy users had a more than eight-fold increased risk of sleep apnea compared to non-users. Mild sleep apnea rates were similar in both groups (21 percent of ecstasy users and 27 percent of non-users), but only ecstasy users had moderate (13 percent) or severe (1 percent) sleep apnea.
The longer a person used ecstasy, the more sleep apnea episodes they experienced, said the researchers. They also found that ecstasy use was a greater risk factor for sleep apnea than obesity.
"Our findings may be explained by how ecstasy damages neurons related to serotonin, a chemical in the brain that is involved in sleep regulation and breathing, among other important functions," McCann said. "Sleep apnea in itself is dangerous, but it can also contribute to thinking problems in people who use ecstasy because chronic sleep disruption is known to have a negative effect on how a person functions during the daytime."
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16] 17
October 17, 2011 | Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide RiskWASHINGTON, June 12, 2008 Senator Chuck Grassley has asked the Food and Drug Administration to carefully scrutinize information it received from drug maker GlaxoSmithKline about the anxiety disorder drug Paxil, based on the contents of a newly ...
September 21, 2009 | Topical cream studied for erectile dysfunctionScientists from Albert Einstein College of Medicine of Yeshiva University are working on a cream to rub on and treat erectile dysfunction (ED). The cream could prove to be safer than oral medications used to deliver nitric oxide to the cells that improves blood flow to treat impotency. Using encapsulated nanoparticles, the scientists have found a way to deliver nitric oxide and prescription drugs that penetrate the tissues to treat erectile dysfunction that ...
May 21, 2012 | Onyx Rises on Analyst View of Blood Cancer DrugNEW YORK -- Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company’s blood cancer drug candidate will reach $1 billion in annual sales by ...
Related articles:
Alprostadil
Alprostadil can be injected into the penis or inserted using a special applicator - usually just before sexual intercourse. Alprostadil has also become available in some countries as a topical cream (under the brand name Befar), and preliminary studies have shown a clinical efficacy of up to 83%. It has an onset of action of 10-15 minutes and its effects can last over 4 hours.Section: Erectile Dysfunction
About mens health risks
Mortality rates for all of the 15 leading causes of death for the total population are higher for males than females in America. Men die almost seven years earlier than women. Men are more likely to suffer from chronic illnesses, to suffer a traumatic brain injury, and to die from acquired immune deficiency syndrome (AIDS). Men are less likely to exercise and are more ...Section: Mens health risks
Treatment - pelvic floor treatments
Work by Wise and Anderson (see details) has shown that urologic pelvic pain syndromes, such as IC/PBS and CP/CPPS, may have no initial trigger other than anxiety, often with an element of Obsessive Compulsive Disorder or other anxiety-spectrum problem. This is theorized to leave the pelvic area in a sensitized condition resulting ...Section: Interstitial cystitis